Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-10-22

FDA Approved: RISPERIDONE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for risperidone from Aurobindo Pharma Limited (generic risperidone).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)